Protara Therapeutics TARA Faces Pressure as Shares Slip 211 Toward Key Support PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate Opus Genetics Inc IRD Q1 2026 Earnings Steep EPS Miss and No Revenue Yet Stock Climbs 381 Dillards Declares 030 Cash Dividend Continuing Shareholder Return Program